APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral COVID-19 Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oral COVID-19 Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025181 pages

Choose your research edition.

Industry ResearchOral COVID-19 Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral COVID-19 Vaccine Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Oral COVID-19 Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral COVID-19 Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral COVID-19 Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Oral COVID-19 Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oral COVID-19 Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral COVID-19 Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral COVID-19 Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oral COVID-19 Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral COVID-19 Vaccine include Shandong Xinhua Pharmaceutical, CanSino Biologics, Kintor Pharmaceutical, Pfizer, Zhejiang Huahai Pharmaceutical Co.,ltd., Henan Genuine Biotech Co., Ltd. and Kindred Biosciences, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral COVID-19 Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral COVID-19 Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral COVID-19 Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral COVID-19 Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral COVID-19 Vaccine Segment by Company

Shandong Xinhua Pharmaceutical

CanSino Biologics

Kintor Pharmaceutical

Pfizer

Zhejiang Huahai Pharmaceutical Co.,ltd.

Henan Genuine Biotech Co., Ltd.

Kindred Biosciences, Inc.

Oral COVID-19 Vaccine Segment by Type

Tablet Type

Inhalable Type

Oral COVID-19 Vaccine Segment by Application

Adults

Children

Elderly

Oral COVID-19 Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral COVID-19 Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral COVID-19 Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral COVID-19 Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral COVID-19 Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral COVID-19 Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oral COVID-19 Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oral COVID-19 Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oral COVID-19 Vaccine Industry Trends Table 2. Oral COVID-19 Vaccine Industry Drivers Table 3. Oral COVID-19 Vaccine Industry Opportunities and Challenges Table 4. Oral COVID-19 Vaccine Industry Restraints Table 5. Global Oral COVID-19 Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oral COVID-19 Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oral COVID-19 Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Oral COVID-19 Vaccine Sales Market Share by Manufacturers Table 9. Global Oral COVID-19 Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Oral COVID-19 Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oral COVID-19 Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oral COVID-19 Vaccine Manufacturers, Product Type & Application Table 13. Global Oral COVID-19 Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral COVID-19 Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablet Type Table 17. Major Manufacturers of Inhalable Type Table 18. Global Oral COVID-19 Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Oral COVID-19 Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global Oral COVID-19 Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global Oral COVID-19 Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Oral COVID-19 Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Oral COVID-19 Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Oral COVID-19 Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global Oral COVID-19 Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global Oral COVID-19 Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Oral COVID-19 Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Adults Table 29. Major Manufacturers of Children Table 30. Major Manufacturers of Elderly Table 31. Global Oral COVID-19 Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Oral COVID-19 Vaccine Sales by Application (2021-2026) & (k units) Table 33. Global Oral COVID-19 Vaccine Sales by Application (2027-2032) & (k units) Table 34. Global Oral COVID-19 Vaccine Sales Market Share by Application (2021-2026) Table 35. Global Oral COVID-19 Vaccine Sales Market Share by Application (2027-2032) Table 36. Global Oral COVID-19 Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Oral COVID-19 Vaccine Revenue by Application (2021-2026) & (k units) Table 38. Global Oral COVID-19 Vaccine Revenue by Application (2027-2032) & (k units) Table 39. Global Oral COVID-19 Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global Oral COVID-19 Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global Oral COVID-19 Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Oral COVID-19 Vaccine Sales by Region (2021-2026) & (k units) Table 43. Global Oral COVID-19 Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Oral COVID-19 Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Oral COVID-19 Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Oral COVID-19 Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Oral COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 48. North America Oral COVID-19 Vaccine Sales by Country (2027-2032) & (k units) Table 49. Europe Oral COVID-19 Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Oral COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 51. Europe Oral COVID-19 Vaccine Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Oral COVID-19 Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Oral COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Oral COVID-19 Vaccine Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Oral COVID-19 Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Oral COVID-19 Vaccine Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Oral COVID-19 Vaccine Sales by Country (2027-2032) & (k units) Table 58. Global Oral COVID-19 Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Oral COVID-19 Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Oral COVID-19 Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Oral COVID-19 Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global Oral COVID-19 Vaccine Revenue Market Share by Region (2027-2032) Table 63. Shandong Xinhua Pharmaceutical Company Information Table 64. Shandong Xinhua Pharmaceutical Business Overview Table 65. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product Portfolio Table 67. Shandong Xinhua Pharmaceutical Recent Development Table 68. CanSino Biologics Company Information Table 69. CanSino Biologics Business Overview Table 70. CanSino Biologics Oral COVID-19 Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. CanSino Biologics Oral COVID-19 Vaccine Product Portfolio Table 72. CanSino Biologics Recent Development Table 73. Kintor Pharmaceutical Company Information Table 74. Kintor Pharmaceutical Business Overview Table 75. Kintor Pharmaceutical Oral COVID-19 Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Kintor Pharmaceutical Oral COVID-19 Vaccine Product Portfolio Table 77. Kintor Pharmaceutical Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Oral COVID-19 Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Pfizer Oral COVID-19 Vaccine Product Portfolio Table 82. Pfizer Recent Development Table 83. Zhejiang Huahai Pharmaceutical Co.,ltd. Company Information Table 84. Zhejiang Huahai Pharmaceutical Co.,ltd. Business Overview Table 85. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product Portfolio Table 87. Zhejiang Huahai Pharmaceutical Co.,ltd. Recent Development Table 88. Henan Genuine Biotech Co., Ltd. Company Information Table 89. Henan Genuine Biotech Co., Ltd. Business Overview Table 90. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product Portfolio Table 92. Henan Genuine Biotech Co., Ltd. Recent Development Table 93. Kindred Biosciences, Inc. Company Information Table 94. Kindred Biosciences, Inc. Business Overview Table 95. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product Portfolio Table 97. Kindred Biosciences, Inc. Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Oral COVID-19 Vaccine Distributors List Table 101. Oral COVID-19 Vaccine Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Oral COVID-19 Vaccine Product Image Figure 2. Global Oral COVID-19 Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral COVID-19 Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral COVID-19 Vaccine Sales (2021-2032) & (k units) Figure 5. Global Oral COVID-19 Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Oral COVID-19 Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablet Type Image Figure 9. Inhalable Type Image Figure 10. Global Oral COVID-19 Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Oral COVID-19 Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Oral COVID-19 Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Oral COVID-19 Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Oral COVID-19 Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Oral COVID-19 Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Adults Image Figure 17. Children Image Figure 18. Elderly Image Figure 19. Global Oral COVID-19 Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Oral COVID-19 Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Oral COVID-19 Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global Oral COVID-19 Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Oral COVID-19 Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Oral COVID-19 Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Oral COVID-19 Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Oral COVID-19 Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Oral COVID-19 Vaccine Sales Market Share by Country (2021-2032) Figure 39. China Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Oral COVID-19 Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Oral COVID-19 Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Oral COVID-19 Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Oral COVID-19 Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Oral COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America Oral COVID-19 Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Oral COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Oral COVID-19 Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Oral COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Oral COVID-19 Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Oral COVID-19 Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Oral COVID-19 Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Oral COVID-19 Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Oral COVID-19 Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet Type
  • Inhalable Type
Applications
  • Adults
  • Children
  • Elderly
Companies covered
  • Shandong Xinhua Pharmaceutical
  • CanSino Biologics
  • Kintor Pharmaceutical
  • Pfizer
  • Zhejiang Huahai Pharmaceutical Co.,ltd.
  • Henan Genuine Biotech Co., Ltd.
  • Kindred Biosciences, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oral COVID-19 Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oral COVID-19 Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oral COVID-19 Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oral COVID-19 Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oral COVID-19 Vaccine Market Dynamics
  1. 2.1 Oral COVID-19 Vaccine Industry Trends
  2. 2.2 Oral COVID-19 Vaccine Industry Drivers
  3. 2.3 Oral COVID-19 Vaccine Industry Opportunities and Challenges
  4. 2.4 Oral COVID-19 Vaccine Industry Restraints
3 Oral COVID-19 Vaccine Market by Manufacturers
  1. 3.1 Global Oral COVID-19 Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oral COVID-19 Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oral COVID-19 Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oral COVID-19 Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral COVID-19 Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oral COVID-19 Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Oral COVID-19 Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral COVID-19 Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral COVID-19 Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral COVID-19 Vaccine Tier 1, Tier 2, and Tier 3
4 Oral COVID-19 Vaccine Market by Type
  1. 4.1 Oral COVID-19 Vaccine Type Introduction
  2. 4.1.1 Tablet Type
  3. 4.1.2 Inhalable Type
  4. 4.2 Global Oral COVID-19 Vaccine Sales by Type
  5. 4.2.1 Global Oral COVID-19 Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oral COVID-19 Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Oral COVID-19 Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Oral COVID-19 Vaccine Revenue by Type
  9. 4.3.1 Global Oral COVID-19 Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Oral COVID-19 Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Oral COVID-19 Vaccine Revenue Market Share by Type (2021-2032)
5 Oral COVID-19 Vaccine Market by Application
  1. 5.1 Oral COVID-19 Vaccine Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.1.3 Elderly
  5. 5.2 Global Oral COVID-19 Vaccine Sales by Application
  6. 5.2.1 Global Oral COVID-19 Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oral COVID-19 Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Oral COVID-19 Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Oral COVID-19 Vaccine Revenue by Application
  10. 5.3.1 Global Oral COVID-19 Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Oral COVID-19 Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Oral COVID-19 Vaccine Revenue Market Share by Application (2021-2032)
6 Global Oral COVID-19 Vaccine Sales by Region
  1. 6.1 Global Oral COVID-19 Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral COVID-19 Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Oral COVID-19 Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Oral COVID-19 Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oral COVID-19 Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oral COVID-19 Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oral COVID-19 Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oral COVID-19 Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oral COVID-19 Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oral COVID-19 Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oral COVID-19 Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oral COVID-19 Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oral COVID-19 Vaccine Revenue by Region
  1. 7.1 Global Oral COVID-19 Vaccine Revenue by Region
  2. 7.1.1 Global Oral COVID-19 Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oral COVID-19 Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Oral COVID-19 Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Oral COVID-19 Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oral COVID-19 Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Oral COVID-19 Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oral COVID-19 Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Oral COVID-19 Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oral COVID-19 Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oral COVID-19 Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oral COVID-19 Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oral COVID-19 Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Shandong Xinhua Pharmaceutical
  2. 8.1.1 Shandong Xinhua Pharmaceutical Company Information
  3. 8.1.2 Shandong Xinhua Pharmaceutical Business Overview
  4. 8.1.3 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product Portfolio
  6. 8.1.5 Shandong Xinhua Pharmaceutical Recent Developments
  7. 8.2 CanSino Biologics
  8. 8.2.1 CanSino Biologics Company Information
  9. 8.2.2 CanSino Biologics Business Overview
  10. 8.2.3 CanSino Biologics Oral COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CanSino Biologics Oral COVID-19 Vaccine Product Portfolio
  12. 8.2.5 CanSino Biologics Recent Developments
  13. 8.3 Kintor Pharmaceutical
  14. 8.3.1 Kintor Pharmaceutical Company Information
  15. 8.3.2 Kintor Pharmaceutical Business Overview
  16. 8.3.3 Kintor Pharmaceutical Oral COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Kintor Pharmaceutical Oral COVID-19 Vaccine Product Portfolio
  18. 8.3.5 Kintor Pharmaceutical Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Oral COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Oral COVID-19 Vaccine Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Zhejiang Huahai Pharmaceutical Co.,ltd.
  26. 8.5.1 Zhejiang Huahai Pharmaceutical Co.,ltd. Company Information
  27. 8.5.2 Zhejiang Huahai Pharmaceutical Co.,ltd. Business Overview
  28. 8.5.3 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product Portfolio
  30. 8.5.5 Zhejiang Huahai Pharmaceutical Co.,ltd. Recent Developments
  31. 8.6 Henan Genuine Biotech Co., Ltd.
  32. 8.6.1 Henan Genuine Biotech Co., Ltd. Company Information
  33. 8.6.2 Henan Genuine Biotech Co., Ltd. Business Overview
  34. 8.6.3 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product Portfolio
  36. 8.6.5 Henan Genuine Biotech Co., Ltd. Recent Developments
  37. 8.7 Kindred Biosciences, Inc.
  38. 8.7.1 Kindred Biosciences, Inc. Company Information
  39. 8.7.2 Kindred Biosciences, Inc. Business Overview
  40. 8.7.3 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product Portfolio
  42. 8.7.5 Kindred Biosciences, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral COVID-19 Vaccine Value Chain Analysis
  2. 9.1.1 Oral COVID-19 Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral COVID-19 Vaccine Production Mode & Process
  6. 9.2 Oral COVID-19 Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral COVID-19 Vaccine Distributors
  9. 9.2.3 Oral COVID-19 Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst